UY27306A1 - Cápsulas elásticas blandas y composiciones de las mismas - Google Patents

Cápsulas elásticas blandas y composiciones de las mismas

Info

Publication number
UY27306A1
UY27306A1 UY27306A UY27306A UY27306A1 UY 27306 A1 UY27306 A1 UY 27306A1 UY 27306 A UY27306 A UY 27306A UY 27306 A UY27306 A UY 27306A UY 27306 A1 UY27306 A1 UY 27306A1
Authority
UY
Uruguay
Prior art keywords
soft elastic
compositions
same
elastic capsule
elastic capsules
Prior art date
Application number
UY27306A
Other languages
English (en)
Inventor
Sergio Petriconi
Alessandro Barbato
Martin Urch
Roberta Scuppa
Azita S-Gerhardt
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY27306A1 publication Critical patent/UY27306A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una cápsula elástica blanda que contiene un agente farmacéutico o una mezcla de agentes farmacéuticos. La cápsula elástica blanda se prepara a partir de una composición de relleno y una composición de revestimiento que confiere características físicas aceptables a dicha cápsula elástica blanda cuando alcanza un estado de equilibrio. Los agentes farmacéuticos de la composición de relleno también son solubles cuando la cápsula elástica blanda está en el estado de equilibrio.
UY27306A 2001-05-25 2002-05-24 Cápsulas elásticas blandas y composiciones de las mismas UY27306A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86628501A 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
UY27306A1 true UY27306A1 (es) 2002-12-31

Family

ID=25347294

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27306A UY27306A1 (es) 2001-05-25 2002-05-24 Cápsulas elásticas blandas y composiciones de las mismas

Country Status (8)

Country Link
EP (1) EP1395249A1 (es)
JP (1) JP2005508294A (es)
AR (1) AR034995A1 (es)
CA (1) CA2448438A1 (es)
MX (1) MXPA03010771A (es)
PE (1) PE20030098A1 (es)
UY (1) UY27306A1 (es)
WO (1) WO2002096395A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
RU2014148964A (ru) 2012-05-03 2016-06-27 Сипла Лимитед Антиретровирусная композиция
WO2019130341A1 (en) * 2017-12-26 2019-07-04 Hetero Labs Limited Capsule compositions comprising lopinavir and ritonavir
GB201917252D0 (en) 2019-11-27 2020-01-08 Pharmaceutic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232333B1 (en) * 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
ATE332132T1 (de) * 1999-06-04 2006-07-15 Abbott Lab Verbesserte arzneizubereitungen enthaltend ritonavir
US6608198B2 (en) * 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical

Also Published As

Publication number Publication date
AR034995A1 (es) 2004-04-14
MXPA03010771A (es) 2004-07-01
JP2005508294A (ja) 2005-03-31
CA2448438A1 (en) 2002-12-05
EP1395249A1 (en) 2004-03-10
WO2002096395A1 (en) 2002-12-05
PE20030098A1 (es) 2003-02-12

Similar Documents

Publication Publication Date Title
BR9814229A (pt) Composição cosmética
CO5840249A1 (es) Composiciones lubricantes personales y equipos para proveer lubricacion personal
BR9714270A (pt) Composição lìquida de limpeza de pele
PE20020968A1 (es) Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
WO2006003481A3 (en) Oleaginous pharmaceutical and cosmetic foam
AR002266A1 (es) Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
HUP9902454A2 (hu) Szubsztituált 1,2,3,4-tetrahidronaftalin-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
BR0111678A (pt) Composições medicinais contendo derivados de propenona
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
UY27306A1 (es) Cápsulas elásticas blandas y composiciones de las mismas
PE20040324A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
DK1847258T4 (da) Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater
HUP0300330A2 (hu) Oligoszacharidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE359248T1 (de) Rauch erzeugende zusammensetzung
ES2136198T3 (es) Composiciones rectales que contienen odansetron en forma de su base libre.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
BRPI0412592A (pt) formulação farmacêutica estável
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141126